The best for your everyday life, recommended by doctors.

Dermastir Dropper Resurfacing Post-op

(3)

65,00

Salīdzināt

The Dermastir resurfacing serum normalizes epidermal renewal to create a noticeably smoother and softer surface texture. 30ml

Parameters:

Packaging / Volume

30 ml

Classification of cosmetics by purpose

For intensive facial skin care

Type of cosmetics

Serums

Purchased a product

More information:

Use of cosmetics

Using fingertips, apply 2-3 drops to the face, neck, and chest, as well as other areas of the body as needed.

Cosmetics composition / formula

Aqua, butylene glycol, glycerin, bis-peg-18 methyl ether dimethyl silane, peg-60 hydrogenated castor oil, caprylic/capric triglyceride, coco-caprylate/caprate, dimethicone, phenoxyethanol, betaine, chlorphenesin, trehalose, phenyl trimethicone, aloe barbadensis leaf extract, hydrogenated lecithin, panthenol, acrylates/c10-30 alkyl acrylate crosspolymer, ethylhexylglycerin, propanediol, caprylyl glycol, tromethamine, cetyl phosphate, disodium edta, parfum, sodium ascorbyl phosphate, beta-glucan, 1,2-hexanediol, sodium hyaluronate, pantolactone

Please be aware that ingredient lists may change or vary from time to time. Please refer to the ingredient list on the product package you receive for the most up to date list of ingredients.

Other information

The Dermastir resurfacing serum normalizes epidermal renewal to create a noticeably smoother and softer surface texture. The ingredients stimulate enzymes that help break the bonds that bind dead cells to the surface of the skin, to dramatically diminish surface lines and wrinkles. Dermastir resurfacing serum speeds skin-cell turnover to improve skin radiance, keeping new, healthy skin on the surface. The skin moisture levels are well balanced and the ingredients reinforce the skin’s barrier.

  • Normalizes epidermal renewal
  • Dramatically diminishes surface lines and wrinkles
  • Speeds skin-cell turnover to improve skin radiance
  • Ingredients reinforce the skin’s barrier

STARPTAUTISKĀS KONKURĒTSPĒJAS VEICINĀŠANAI
SIA “Flebomedika” ir noslēdzis 2016. Gada 16. Septembrī līgumu Nr.SKV-L_2016/785 ar Latvijas Investīciju un attīstības aģentūru par atbalsta saņemšanu pasākuma « Starptautiskās konkurētspējas veicināšana » ietvaros, ko līdzfinansē Eiropas Reģionālās attīstības fonds